167 related articles for article (PubMed ID: 3022146)
1. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma.
Fossel ET; Carr JM; McDonagh J
N Engl J Med; 1986 Nov; 315(22):1369-76. PubMed ID: 3022146
[TBL] [Abstract][Full Text] [Related]
2. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.
Okunieff P; Zietman A; Kahn J; Singer S; Neuringer LJ; Levine RA; Evans FE
N Engl J Med; 1990 Apr; 322(14):953-8. PubMed ID: 2314447
[TBL] [Abstract][Full Text] [Related]
3. [NMR research on blood plasma for tumor detection--a method for mass screening?].
Fritzsche H; Sprinz H; Jahn H; Jorke D
Arch Geschwulstforsch; 1989; 59(2):129-33. PubMed ID: 2719533
[TBL] [Abstract][Full Text] [Related]
4. Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer.
Engan T; Krane J; Klepp O; Kvinnsland S
N Engl J Med; 1990 Apr; 322(14):949-53. PubMed ID: 2314446
[TBL] [Abstract][Full Text] [Related]
5. [Prostatic tumors. Detection by proton nuclear magnetic resonance spectroscopy of plasma lipoproteins].
Nabholtz JM; Tremeaux JC; Rossignol A; Farnier M; Gambert P; Briet S; Guerrin J
J Urol (Paris); 1989; 95(4):209-12. PubMed ID: 2477463
[TBL] [Abstract][Full Text] [Related]
6. Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma.
Mims MP; Morrisett JD; Mattioli CA; Gotto AM
N Engl J Med; 1989 Jun; 320(22):1452-7. PubMed ID: 2716796
[TBL] [Abstract][Full Text] [Related]
7. Early changes in the 1H-NMR plasma spectrum in patients following breast surgery.
Engan T; Krane J; Søreide JA; Bjerve KS; Kvinnsland S
Eur J Surg Oncol; 1993 Apr; 19(2):115-22. PubMed ID: 8491314
[TBL] [Abstract][Full Text] [Related]
8. [H-NMR spectroscopy of plasma cannot be used for cancer screening].
Tran Dinh S; Schlumberger M; Gicquel C; Neumann JM; Hervé M; Turpin G; Parmentier C
Bull Cancer; 1988; 75(8):795-800. PubMed ID: 3179513
[TBL] [Abstract][Full Text] [Related]
9. The NMR blood test for cancer: current status.
Fossel ET
Cancer Cells; 1991 May; 3(5):173-82. PubMed ID: 1654067
[TBL] [Abstract][Full Text] [Related]
10. An NMR blood test for uveal melanoma?
Smith EV; Kolodny NH; Gragoudas ES; Egan KM; Finn S; D'Amico DJ; Seddon JM
Invest Ophthalmol Vis Sci; 1990 May; 31(5):993-7. PubMed ID: 2335461
[TBL] [Abstract][Full Text] [Related]
11. The value of combined use of serum tumour markers and nuclear magnetic spectroscopy of plasma in the detection of pancreatic cancer among patients with jaundice or cholestasis: results from a prospective study.
Pasanen PA; Kauppinen R; Eskelinen M; Partanen K; Pikkarainen P; Alhava E
Anticancer Res; 1993; 13(3):763-8. PubMed ID: 8317910
[TBL] [Abstract][Full Text] [Related]
12. Proton NMR spectroscopy of plasma lipoproteins: a marker of the immune function in cancer disease?
Leray G; de Certaines JD
Anticancer Res; 1994; 14(5A):1839-51. PubMed ID: 7847817
[TBL] [Abstract][Full Text] [Related]
13. Magnetic resonance spectroscopy of blood plasma lipoproteins in malignant disease: methodological aspects and clinical relevance.
Engan T
Anticancer Res; 1996; 16(3B):1461-71. PubMed ID: 8694514
[TBL] [Abstract][Full Text] [Related]
14. Proton nuclear magnetic resonance spectroscopy of plasma lipoproteins in malignancy.
Nabholtz JM; Rossignol A; Farnier M; Gambert P; Tremeaux JC; Friedman S; Guerrin J
Acta Oncol; 1988; 27(5):479-82. PubMed ID: 3203006
[TBL] [Abstract][Full Text] [Related]
15. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
16. Detection of malignant tumors by nuclear magnetic resonance spectroscopy of plasma.
N Engl J Med; 1987 May; 316(22):1411-5. PubMed ID: 3574419
[No Abstract] [Full Text] [Related]
17. Preliminary study of 3T 1H MR spectroscopy in bone and soft tissue tumors.
Qi ZH; Li CF; Li ZF; Zhang K; Wang Q; Yu DX
Chin Med J (Engl); 2009 Jan; 122(1):39-43. PubMed ID: 19187615
[TBL] [Abstract][Full Text] [Related]
18. Proton MR spectroscopy in normal breasts between pre- and postmenopausal women: a preliminary study.
Wang J; Torng PL; Liu TP; Chen KL; Shih TT
AJR Am J Roentgenol; 2008 Feb; 190(2):505-10. PubMed ID: 18212239
[TBL] [Abstract][Full Text] [Related]
19. Assessment of proton nuclear magnetic resonance spectroscopy for detection of malignancy.
Wilding P; Senior MB; Inubushi T; Ludwick ML
Clin Chem; 1988 Mar; 34(3):505-11. PubMed ID: 3349601
[TBL] [Abstract][Full Text] [Related]
20. Proton nuclear magnetic resonance spectroscopy measurements of methylene and methyl line widths in plasma: significant variations with extent of breast cancer, duration of pregnancy and aging.
Engan T; Krane J; Kvinnsland S
NMR Biomed; 1991 Jun; 4(3):142-9. PubMed ID: 1911102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
